https://www.nrgtherapeutics.com/wp-content/uploads/2026/09/LT_080926.jpg8001200Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-09-08 10:04:432026-09-14 10:10:15New ALS drug data reveal a mitochondrial fix
https://www.nrgtherapeutics.com/wp-content/uploads/2026/09/BioUK_040926.png7201200Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-09-04 10:03:522026-09-14 10:04:37Coulter Partners places Claus Sundgreen, M.D. as Chief Medical Officer at NRG Therapeutics
https://www.nrgtherapeutics.com/wp-content/uploads/2026/09/P_250826.jpg6501024Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-08-25 10:03:042026-09-14 10:07:30NRG5051 Targets mPTP Through Novel NLRX1 Mechanism in ALS
https://www.nrgtherapeutics.com/wp-content/uploads/2026/09/DDW_250826.jpg533800Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-08-25 10:02:072026-09-14 10:02:47New drug displays anti-inflammatory and neuroprotective effects in ALS
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/NRG-Therapeutics-spotlight-film.jpg400600Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-03-27 08:00:502026-08-14 11:19:05NRG Therapeutics CEO Spotlight Video SBC
https://www.nrgtherapeutics.com/wp-content/uploads/2026/02/ScripAsks_NRG.jpg394596Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-02-06 08:00:372026-08-14 14:55:55Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/BusinessWeekly_NRG.jpg8191238Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-01-28 08:00:162026-08-14 11:19:20Founder-CEO Interview Series
https://www.nrgtherapeutics.com/wp-content/uploads/2026/08/Shutterstock_657435445-1200x800-c-default.jpg8001200Webadmhttps://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.pngWebadm2026-01-26 08:01:292026-08-14 13:36:48Disease-modifying treatment for ALS enters Phase I
